The Big Diabetes Lie

Natural Diabetes Cure and Treatment

Get Instant Access

Brickman WJ, Howard JC, Metzger BE. Abnormal glucose tolerance in children with acan-thosis nigricans: a chart review. Diabetes 2002;51(2):A429.

Nguyen TT, Keil MF, Russell DL, et al. Relation of acanthosis nigricans to hyperinsulinemia and insulin sensitivity in overweight African American and white children. J Pediatr 2001; 138(4):474-80.

Hirschler V, Aranda C, Oneto A, et al. Is acanthosis nigricans a marker of insulin resistance in obese children? Diabetes Care 2002;25(12):2353.

Hales CN, Barker DJ. The thrifty phenotype hypothesis. Br Med Bull 2001;60:5-20. Pettitt DJ, Baird HR, Aleck KA, et al. Diabetes mellitus in children following maternal diabetes during gestation. Diabetes 1982;31:66A.

Pettitt DJ, Baird HR, Aleck KA, et al. Excessive obesity in offspring of Pima Indian women with diabetes during pregnancy. N Engl J Med 1983;308(5):242-5.

Silverman BL, Metzger BE, Cho NH, et al. Impaired glucose tolerance in adolescent offspring of diabetic mothers: relationship to fetal hyperinsulinism. Diabetes Care 1995;18(5):611-7. Silverman BL, Rizzo TA, Cho NH, et al. Long-term effects of the intrauterine environment: the Northwestern University Diabetes in Pregnancy Center. Diabetes Care 1998;21(Suppl 2): B142-9.

Barker DJP, Hales CN, Fall CHD, et al. Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): relation to reduced fetal growth. Diabetologia 1993;36(1):62-7.

Robinson S, Walton RJ, Clark PM, et al. The relation of fetal growth to plasma glucose in young men. Diabetologia 1992;35(5):444-6.

Jaquet D, Gaboriau A, Czernichow P, et al. Insulin resistance early in adulthood in subjects born with intrauterine growth retardation. J Clin Endocrinol Metab 2000;85(4):1401-6. Hattersley A, Tooke J. The fetal insulin hypothesis: an alternative explanation of the association of low birth weight with diabetes and vascular disease. Lancet 1999;353(9166):1789-92. Hofman PL, Cutfield WS, Robinson EM, et al. Insulin resistance in short children with intrauterine growth retardation. J Clin Endocrinol Metab 1997;82(2):402-6. Ong K, Petry C, Emmett P, et al. Insulin sensitivity and secretion in normal children related to size at birth, postnatal growth, and plasma insulin-like growth factor-I levels. Diabetologia 2004;47(6):1064-70.

Veening MA, van Weissenbruch MM, Delemarre-van de Waal HA. Glucose tolerance, insulin sensitivity, and insulin secretion in children born small for gestational age. J Clin Endo-crinol Metab 2002;87(10):4657-61.

Jensen CB, Storgaard H, Dela F, et al. Early differential defects of insulin secretion and action in 19-year-old Caucasian men who had low birth weight. Diabetes 2002;51(4):1271-80. Whincup PH, Cook DG, Adshead F, et al. Childhood size is more strongly related than size at birth to glucose and insulin levels in 10-11 year old children. Diabetologia 1997;40(3):319-26. Wilkin TJ, Metcalf BS, Murphy MJ, et al. The relative contributions of birth weight, weight change, and current weight to insulin resistance in contemporary 5-year-olds. Diabetes 2002; 51(12):3468-72.

Bavdekar A, Yajnik CS, Fall CHD, et al. Insulin resistance syndrome in 8-year-old Indian children. Diabetes 1999;48(12):2422-9.

Garnett SP, Cowell CT, Baur LA, et al. Abdominal fat and birth size in healthy prepubertal children. Int J Obes 2001;25(11):1667-73.

Weiss R, Dziura J, Burgert TS, et al. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med 2004;350(23):2362-74.

Hannon T, Arslanian S. Can we use simple clinical markers to identify overweight youth with insulin resistance? Diabetes 2005;54(Suppl 1):A52.

American Diabetes Association. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2005;28(Suppl 1):S37-42. American Diabetes Association. Report of the expert committee on the diagnosis and classification of diabetes mellitus: follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003;26(11):3160-7.

[133] Hollander P. The case for tight control in diabetes. Postgrad Med 1984;75(4):80-7.

[134] McGill H, McMahan CA. Determinants of atherosclerosis in the young: pathobiological determinants of atherosclerosis in youth (PDAY) research group. Am J Cardiol 1998;82(10B):30T-6T.

[135] The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-86.

[136] Shaw J, Zimmet P, McCarty D, et al. Type 2 diabetes worldwide according to the new classification and criteria. Diabetes Care 2000;23(Suppl 2):B5-10.

[137] Shaw J, Hodge A, de Courten M, et al. Isolated post-challenge hyperglycaemia confirmed as a risk factor for mortality. Diabetologia 1999;42(9):1050-4.

[138] Sinha R, Fisch G, Teague B, et al. Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. N Engl J Med 2002;346(11):802-10.

[139] Libman I, Marcus M, Kalarchian M, et al. Impaired fasting glucose according to the new ADA criteria: does it identify more youth at risk for cardiovascular disease? Diabetes 2004; 53(Suppl 2):294.

[140] Uwaifo GI, Elberg J, Yanovski JA. Impaired glucose tolerance in obese children and adolescents. N Engl J Med 2002;347(4):290-2.

[141] Invitti C, Gilardini L, Viberti G. Impaired glucose tolerance in obese children and adolescents [author's reply]. N Engl J Med 2002;347(4):290-2.

[142] Kitagawa T, Mano T, Fujita H. The epidemiology of childhood diabetes mellitus in Tokyo metropolitan area. Tohoku J Exp Med 1983;141:171-9.

[143] Pinhas-Hamiel O, Dolan LM, Zeitler PS. Diabetic ketoacidosis among obese African-American adolescents with NIDDM. Diabetes Care 1997;20(4):484-6.

[144] Maldonado M, Hampe CS, Gaur LK, et al. Ketosis-prone diabetes: dissection of a heterogeneous syndrome using an immunogenetic and beta-cell functional classification, prospective analysis, and clinical outcomes. J Clin Endocrinol Metab 2003;88(11):5090-8.

[145] Mauvais-Jarvis F, Smith SB, Le May C, et al. PAX4 gene variations predispose to ketosis-prone diabetes. Hum Mol Genet 2004;13(24):3151-9.

[146] Winter WE, Maclaren NK, Riley WJ, et al. Maturity-onset diabetes of youth in black Americans. N Engl J Med 1987;316(6):285-91.

[147] Banerji MA, Chaiken RL, Huey H, et al. GAD antibody negative NIDDM in adult black subjects with diabetic ketoacidosis and increased frequency of human leukocyte antigen DR3 and DR4: flatbush diabetes. Diabetes 1994;43(6):741-5.

[148] Umpierrez GE, Casals MM, Gebhart SP, et al. Diabetic ketoacidosis in obese African-Americans. Diabetes 1995;44(7):790-5.

[149] Rasouli N, Elbein SC. Improved glycemic control in subjects with atypical diabetes results from restored insulin secretion, but not improved insulin sensitivity. J Clin Endocrinol Metab 2004;89(12):6331 -5.

[150] McFarlane SI, Chaiken RL, Hirsch S, et al. Near-normoglycaemic remission in African-Americans with type 2 diabetes mellitus is associated with recovery ofbeta cell function. Diabet Med 2001;18(1):10-6.

[151] Libman IM, Pietropaolo M, Arslanian SA, et al. Changing prevalence of overweight children and adolescents at onset of insulin-treated diabetes. Diabetes Care 2003;26(10):2871-5.

[152] Bingley PJ, Bonifacio E, Shattock M, et al. Can islet cell antibodies predict IDDM in the general population? Diabetes Care 1993;16(1):45-50.

[153] Hagopian WA, Sanjeevi CB, Kockum I, et al. Glutamate decarboxylase-, insulin-and islet cell-antibodies and HLA typing to detect diabetes in a general population-based study of Swedish children. J Clin Invest 1995;95(4):1505-11.

[154] Knip M, Karjalainen J, Akerbloom HK. Islet cell antibodies are less predictive of IDDM among unaffected children in the general population than in sibs of children with diabetes: the Childhood Diabetes in Finland Study Group. Diabetes Care 1998;21(10):1670-3.

[155] Tuomi T, Groop LC, Zimmet PZ, et al. Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin-dependent onset of disease. Diabetes 1993;42(2):359-62.

Was this article helpful?

0 0
The Ketosis Plan Diet

The Ketosis Plan Diet

Top Low Carb Internet Guru Speaks Out. An Open Letter To Anyone Who Wants To Lose Up To 20 Pounds In 30 Days The 'Low Carb' Way. 30-Day Low Carb Diet 'Ketosis Plan' has already helped scores of people lose their excess pounds and inches faster and easier than they ever thought possible. Why not find out what 30-Day Low Carb Diet 'Ketosis Plan' can do for you by trying it out for yourself.

Get My Free Ebook

Post a comment